Product Information

RHOFADE 1% CREAM is a brand product labeled by Mayne Pharma, priced at $23.4657 per GM under NDC 51862076530. Its NADAC has been published 72 times since Feb 12, 2025.

The High Outlier badge above means this manufacturer's average price in the oxymetazoline hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RHOFADE 1% CREAM

oxymetazoline hydrochloride
$23.4657per GM
High Outlier

Strength

10 mg/g

Manufacturer

Mayne Pharma

NDC

51862076530

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

6/17/2026

Active Ingredients

OXYMETAZOLINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA208552

On Market Since

10/24/2024

Pharmacological Classes

Imidazolines
Increased Sympathetic Activity
Vasoconstriction
Vasoconstrictor

Price Statistics

The NADAC for RHOFADE 1% CREAM has been published 72 times since Feb 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$23.4657 per GM
All-time high$23.4862 (Dec 10, 2025)
All-time low$21.9772 (Jul 23, 2025)
52-week high$23.4862
52-week low$21.9772
Median price$23.4629
Average price$23.1826
Largest weekly change-6.4% (Jul 23, 2025)
Weeks tracked72
Tracking sinceFeb 12, 2025

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

+0.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the oxymetazoline hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of RHOFADE 1% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for RHOFADE 1% CREAM, manufactured by Mayne Pharma, is $23.4657 per GM (NDC 51862076530), effective Jun 24, 2026.

How has the price of RHOFADE 1% CREAM changed over time?

Over the history we have for it, the NADAC for RHOFADE 1% CREAM has held within roughly two percent of its current level. It has been tracked across 72 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for RHOFADE 1% CREAM?

Since Feb 12, 2025, the NADAC for RHOFADE 1% CREAM has ranged from a low of $21.9772 (Jul 23, 2025) to a high of $23.4862 (Dec 10, 2025), with a median of $23.4629 per GM.

Are there cheaper alternatives to RHOFADE 1% CREAM?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RHOFADE 1% CREAM, so no direct lower-cost alternative is listed.

Who manufactures RHOFADE 1% CREAM?

RHOFADE 1% CREAM (NDC 51862076530) is labeled by Mayne Pharma, and CMS classifies it as a brand product.